Results The data demonstrate a significant increase in global occupancy levels of MeCP2
and H3K9ac markers and a decrease of H3K9me2 to chromatin in CCs of PCOS patients vs …

Aims: This study aimed to examine the methylation status of the CYP19A1 promoter region
in Chinese polycystic ovary syndrome (PCOS) patients. Methods: A case-control study was …

Aims: This research analyzed the role of the aromatase gene (CYP19A1) in PCOS
pathogenesis. Settings and Design: This study used an observational, cross-sectional …

The aim of this study was to assess the rates of variant alleles of cytochrome P4501A1
(CYP1A1) in patients with polycystic ovary syndrome (PCOS). It was designed as a case …

Purpose The purpose of the present study was to investigate the epigenetic mechanisms
responsible for the aberrant aromatase expression (CYP19A1) in Cumulus Cells (CCs) of …

Background: This study designed to detect the relation between the aromatase CYP19 gene
SNP50 variation and hyperandrogenism in polycystic ovary syndrome (PCOS) Egyptian …

The polycystic ovary syndrome (PCOS) is a heterogeneous multifactorial endocrine
metabolic disorder with genetic predisposition affecting 6% of women in the reproductive …

Polycystic ovarian syndrome (PCOS) is a prevalent endocrine disorder, which is the most
common cause of anovulatory infertility and hirsutism. It is caused by an overproduction of …

Background Polycystic ovary syndrome (PCOS) is a common and chronic disorder of
endocrine glands where genetic factors play a major role in the susceptibility to the disease …

OBJECTIVE: To evaluate the possible contribution of the (TTTA) n polymorphism of
aromatase gene (CYP19) to the hyperandrogenic phenotype of polycystic ovary syndrome …